Facing its weakest annual profit in years, Eastman Chemical is doubling down on cost reductions while banking on its molecular recycling technology to fuel a turnaround by 2026, despite a challenging global economic climate.
Barclays initiates coverage of 4D Molecular Therapeutics with an Overweight rating and a $33 price target, citing a favorable industry backdrop with potential M&A tailwinds and shifting focus away from drug pricing pressures. The gene therapy developer also outlined key clinical milestones expected through 2026.
While Q3 earnings reflect challenging market conditions, the chemical giant reports strong North American performance and accelerates its strategic shift, breaking ground on a flagship advanced recycling plant in Germany and planning a larger facility in Houston.
Brookfield Business Partners reported a robust 2025, generating over $2 billion from asset sales, reducing debt, and making strategic acquisitions. The firm is on the cusp of a major corporate restructuring into a single listed entity, aiming to boost liquidity and investor appeal in a shifting global landscape.
The new campus in McBee, SC, aims to bolster North American supply chains for critical minerals, starting with a 2,000-ton annual processing capacity for magnet scrap.
Becton Dickinson announces a major spin-off of its Biosciences unit to combine with Waters Corporation, alongside a successful pilot to recycle polystyrene labware, signaling a dual push towards portfolio focus and sustainability.
While the German market gained a modest 7.7%, steel dust recycling leader Befesa (ETR:BFSA) delivered a total shareholder return of 54% over the past twelve months. This impressive rebound follows a challenging three-year period, sparking investor debate on whether it signals a sustained recovery or a temporary rally.
While outlining stabilization efforts in challenged segments like Fibers, Eastman Chemical's leadership emphasized that a sustained recovery hinges on broader end-market demand. The company is betting on strategic projects and chemical recycling to drive future growth amid persistent pricing pressures and global trade dynamics.
The protective packaging leader's 2025 recycling achievement, driven by customer partnerships and its EmeraldPak product, marks a significant step in its 'Stairway to Green' initiative and underscores growing industry momentum for closed-loop systems.
Brookfield Infrastructure Partners capped a strong 2025 with double-digit FFO growth, a record capital recycling program, and a raised distribution. Management highlighted a massive, disciplined expansion in data infrastructure to meet AI-driven demand, forecasting a return to 10%+ growth targets.
UK retail property specialist NewRiver REIT signals a resilient operational performance in its third quarter, driven by sustained consumer spending and strategic capital recycling, while navigating business rate changes.
A damning report from the European Court of Auditors reveals the bloc is falling dangerously behind in securing the lithium, cobalt, and nickel needed for its energy transition, leaving climate goals and strategic autonomy in jeopardy.
A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, citing insufficient evidence. The complaint stemmed from the judge's rulings against the Trump administration's use of the Alien Enemies Act to deport Venezuelan migrants.
A federal appeals court has dismissed a Justice Department misconduct complaint against U.S. District Judge James Boasberg, ruling the government failed to substantiate its allegations regarding the judge's public comments.
The White House has confirmed the launch of a major strategic initiative to stockpile rare earth elements, aiming to reduce American dependence on China for the critical minerals used in defense tech and consumer electronics.
BeOne Medicines extends its collaboration with quantitative systems pharmacology firm InSysBio, aiming to optimize clinical trial dosing and mitigate cytokine release syndrome risks across its broad portfolio of 15 novel oncology assets.
While the sub-$10 stock universe offers potential for significant returns, it demands rigorous scrutiny. We analyze one company with a compelling growth thesis and two others where investors should proceed with caution.
Chinese electric vehicle maker NIO reports a near-doubling of January deliveries year-over-year, surpassing one million cumulative vehicles. The company is pushing into new markets in Europe and Asia while rolling out a major driver-assistance system upgrade to its existing fleet, even as it navigates subsidy reductions and intensifying competition at home.
A federal appeals court has thrown out a Justice Department misconduct complaint against a judge who blocked deportations to El Salvador's notorious prisons, citing a lack of evidence. The ruling highlights ongoing tensions between the judiciary and executive branch over immigration enforcement.
AT&T's landmark deal to acquire Lumen's fiber assets signals a major strategic pivot, creating a new open-access network subsidiary to expand its broadband reach and challenge rivals Verizon and T-Mobile.
